1. Home
  2. TNGX vs KBSX Comparison

TNGX vs KBSX Comparison

Compare TNGX & KBSX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TNGX
  • KBSX
  • Stock Information
  • Founded
  • TNGX 2014
  • KBSX 1976
  • Country
  • TNGX United States
  • KBSX Taiwan
  • Employees
  • TNGX N/A
  • KBSX N/A
  • Industry
  • TNGX Biotechnology: Pharmaceutical Preparations
  • KBSX Recreational Games/Products/Toys
  • Sector
  • TNGX Health Care
  • KBSX Consumer Discretionary
  • Exchange
  • TNGX Nasdaq
  • KBSX Nasdaq
  • Market Cap
  • TNGX 723.2M
  • KBSX 74.8M
  • IPO Year
  • TNGX N/A
  • KBSX N/A
  • Fundamental
  • Price
  • TNGX $7.88
  • KBSX $1.62
  • Analyst Decision
  • TNGX Strong Buy
  • KBSX
  • Analyst Count
  • TNGX 6
  • KBSX 0
  • Target Price
  • TNGX $10.00
  • KBSX N/A
  • AVG Volume (30 Days)
  • TNGX 1.5M
  • KBSX 14.0K
  • Earning Date
  • TNGX 11-05-2025
  • KBSX 08-21-2025
  • Dividend Yield
  • TNGX N/A
  • KBSX N/A
  • EPS Growth
  • TNGX N/A
  • KBSX N/A
  • EPS
  • TNGX N/A
  • KBSX N/A
  • Revenue
  • TNGX $24,296,000.00
  • KBSX $40,863,331.00
  • Revenue This Year
  • TNGX $20.42
  • KBSX N/A
  • Revenue Next Year
  • TNGX N/A
  • KBSX N/A
  • P/E Ratio
  • TNGX N/A
  • KBSX N/A
  • Revenue Growth
  • TNGX N/A
  • KBSX 20.42
  • 52 Week Low
  • TNGX $1.03
  • KBSX $1.26
  • 52 Week High
  • TNGX $10.81
  • KBSX $15.48
  • Technical
  • Relative Strength Index (RSI)
  • TNGX 66.61
  • KBSX 42.17
  • Support Level
  • TNGX $6.38
  • KBSX $1.61
  • Resistance Level
  • TNGX $6.90
  • KBSX $1.66
  • Average True Range (ATR)
  • TNGX 0.45
  • KBSX 0.02
  • MACD
  • TNGX 0.06
  • KBSX -0.00
  • Stochastic Oscillator
  • TNGX 95.88
  • KBSX 11.11

About TNGX Tango Therapeutics Inc.

Tango Therapeutics Inc is a biotechnology company. It is dedicated to discovering novel drug targets and delivering the next generation of precision medicine for the treatment of cancer. It is engaged in the business of discovering and developing precision oncology therapies. It is currently developing two MTA-cooperative PRMT5 inhibitors; TNG462 for non-CNS cancers, including pancreatic and lung cancer, and TNG456, a next-generation, brain-penetrant PRMT5 inhibitor, for CNS cancers, including GBM. Its pipeline products are PRMT5 and CoREST.

About KBSX FST Corp. Ordinary Shares

FST Corp is a renowned manufacturer and innovator in the golf industry with a growing portfolio of creative golf products, including acclaimed golf club shafts and other equipment. The Company has engaged in the research, development, manufacturing, and sales of golf club shafts. The Company currently produces and sells golf club shafts under the Company's own high performance KBS golf club shaft brand, and serves as an original equipment manufacturer (OEM) and original design manufacturer (ODM) for other world-renowned golf equipment brands, golf equipment OEMs, and golf equipment distributors that provide consumers with customized golf club services.

Share on Social Networks: